missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Verapamil EP Impurity M (Verapamil USP Related Compound D) as Hydrochloride, Mikromol™
Beskrivelse
Verapamil EP Impurity M (Verapamil USP Related Compound D) as Hydrochloride
Tekniske data
Tekniske data
| Kemisk navn eller materiale | 5,5'-[(2-(3,4-Dimethoxyphenyl)ethyl)imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)-pentanenitrile] Hydrochloride |
| CAS | 190850-50-1 |
| Analyt- eller komponentnavne | 5,5'-[(2-(3,4-Dimethoxyphenyl)ethyl)imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)-pentanenitrile] Hydrochloride |
| Forsendelsestilstand | Room Temperature |
| Molekylær formel | C42 H57 N3 O6 . Cl H |
| Certificeringer/compliance | ISO 17025 |
| Synonym | 5,5'-[[2-(3,4-Dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)-pentanenitrile] Hydrochloride, Verapamil Hydrochloride Imp. M (EP), Verapamil Imp. M (EP), Benzeneacetonitrile, alpha,alpha'-[[[2-(3,4-dimethoxyphenyl)ethyl]imino]di-3,1-propanediyl]bis[3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride (9CI), Verapamil Related Compound D as Hydrochloride, Verapamil Hydrochloride Impurity M as Hydrochloride, Verapamil Impurity M as Hydrochloride |
| InChI formel | InChI=1S/C42H57N3O6.ClH/c1-30(2)41(28-43,33-14-17-36(47-6)39(26-33)50-9)20-11-22-45(24-19-32-13-16-35(46-5)38(25-32)49-8)23-12-21-42(29-44,31(3)4)34-15-18-37(48-7)40(27-34)51-10;/h13-18,25-27,30-31H,11-12,19-24H2,1-10H3;1H |
| SMIL | Cl.COc1ccc(CCN(CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)CCCC(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC |
| IUPAC navn | 5-[[4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-(3,4-dimethoxyphenyl)-2-propan-2-ylpentanenitrile;hydrochloride |
| Vis mere |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?